The current valuation score of Collplant Biotechnologies Ltd is 6.17, ranking 356 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.36, which is -1.23% below the recent high of -0.35 and -3644.76% above the recent low of -13.41.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.